THE MORGRIDGE INSTITUTE FOR RESEARCH INC

Programs
Program 1 [2021]
REGENERATIVE BIOLOGY: UNDERSTANDING AND DIRECTING CELLULAR FATES TO IMPROVE HEALTH- CREATE PHYSIOLOGICALLY STABLE, SAFE AND FUNCTIONAL CELLS TO BETTER UNDERSTAND THE HUMAN BODY.- APPLY KNOWLEDGE ABOUT CELLUAR GENERATION FOR APPLICATION IN PREVENTION AND TREATMENT OF DEGENERATIVE DISEASES.- APPLY KNOWLEDGE TO DEVELOP AND TAILOR DRUGS FOR SPECIFIC NEEDS.GeographiesNot indicatedDatesJul 1, 2020 – Jun 30, 2021Source990No causes providedNo populations provided–$6.3MProgram 2 [2021]
BIOMEDICAL IMAGING: ADVANCING TECHNOLOGIES TO BETTER DIAGNOSE, TREAT AND PREVENT DISEASE-TRANSIENT LIGHTING FOR SURGERY: DEVELOPMENT OF A RAPID-SWITCH LIGHTING SYSTEM THAT PROVIDES FULL LIGHT IN THE OPERATING ROOM, WHILE PROTECTING LIGHT-SENSITIVE FLUORESCENCE IMAGES OF USE TO SURGEONS.-BETTER CT IMAGES: DEVELOPING A MULTI-SOURCE X-RAY TUBE FOR COMPUTED TOMOGRAPHY (CT) - ONE OF THE MOST WIDELY USED TOOLS TO IMAGE DISEASE - TO ENABLE FASTER IMAGING, DOSE REDUCTION, AND IMPROVED IMAGE QUALITY.-IMPROVED BREAST CANCER TRACKING: CREATING AN IMAGING SYSTEM TO TRACK BREAST CANCER BASED ON ALIGNMENT OF COLLAGEN FIBERS, WHICH ARE BIOMARKERS FOR BREAST CANCER METASTASIS.GeographiesNot indicatedDatesJul 1, 2020 – Jun 30, 2021Source990No causes providedNo populations provided–$4.1MProgram 3 [2021]
METABOLISM: - ELUCIDATING THE CHEMISTRY OF LIFE AND ITS DISRUPTION IN HUMAN DISEASE- MITOCHONDRIA AND DISEASE: UNLOCKING FUNCTION OF THE MITOCHONDRIA, OR "CELLULAR POWERHOUSE," TO UNDERSTAND ITS ROLE IN MORE THAN 150 DISEASES, INCLUDING PARKINSON'S, DIABETES, AND CANCER. - ORPHAN PROTEINS: ESTABLISHING A RESEARCH PLATFORM TO STUDY THE MORE THAN 100 PROTEINS - NEARLY ONE-QUARTER OF THE MAMMALIAN MITOCHONDRIAL PROTEOME - THAT HAVE A YET UNDISCOVERED BIOCHEMICAL FUNCTION.- COENZYME Q: INTEGRATING VARIOUS BIOCHEMICAL, GENETIC AND STRUCTURAL BIOLOGY APPROACHES TO FURTHER ELUCIDATE THE STEPS OF COENZYME Q, WHOSE DEFICIENCY IS ASSOCIATED WITH MULTIPLE HUMAN DISEASES.GeographiesNot indicatedDatesJul 1, 2020 – Jun 30, 2021Source990No causes providedNo populations provided–$1.8M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)